Medical technology company Stryker has introduced the new Gamma4 System for the treatment of stable and unstable fractures.

With the newest Gamma System, surgeons will get access to the company’s next-generation intramedullary nailing system, which has also been designed to stabilise bones.

The Gamma4 System is also indicated to correct bone deformities in the intracapsular, subtrochanteric, trochanteric, and shaft regions of the femur, which include osteoporotic and osteopenic bone.

It features a precision pin, which reduces the potential for skiving by 66% compared to a standard ∅3.2 k-wire.

The SOMA-designed nail of the system includes length-dependent RoC long nails, chamfered distal tip, and shortened proximal body with a pre-inserted and cannulated set screw.

Stryker stated that the new Gamma4 System also features an integrated platform.

Stryker Trauma business vice-president and general manager Eric Tamweber said: “Since 2004, the Gamma3 System has been the proven workhorse of our Trauma business.

“But we aren’t proven because we have a legacy; we have a legacy because we are proven.

“That’s why we’re so excited to introduce Gamma4 – an enhanced, modern product that is designed to fulfil our customers’ hip fracture needs.”

In September last year, Stryker introduced the Citrelock Tendon Fixation Device System.

The system was designed to enable fixation without causing damage to the tendon during placement.

Citrelock Tendon Fixation Device System offers a controlled and homogeneous resorption process while preventing bulk degradation and chronic inflammation

It also offers surgeons a strength similar to cortical bone and a modulus in line with cancellous bone.